Evogene's Q3 Revenues Rise Sharply, Swings to Profit | GenomeWeb

NEW YORK (GenomeWeb News) – Evogene today reported that its third-quarter revenues increased nearly three-fold year over year, and it swung to a profit from a loss.

The Rehovot, Israel-based firm reported total revenues of $2.6 million for the three-month period ended Sept. 30, 2009, compared to $870,000 for the third quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.